Anti-FCERG/ FCER1G/ FCRG monoclonal antibody

Anti-FCERG/ FCER1G/ FCRG antibody for FACS & in-vivo assay

Target products collectionGo to FCERG/FCER1G products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T95400-Ab-1/ GM-Tg-hg-T95400-Ab-2Anti-Human FCERG/FCER1G monoclonal antibodyHuman
GM-Tg-rg-T95400-Ab-1/ GM-Tg-rg-T95400-Ab-2Anti-Rat FCERG/FCER1G monoclonal antibodyRat
GM-Tg-mg-T95400-Ab-1/ GM-Tg-mg-T95400-Ab-2Anti-Mouse FCERG/FCER1G monoclonal antibodyMouse
GM-Tg-cynog-T95400-Ab-1/ GM-Tg-cynog-T95400-Ab-2Anti-Cynomolgus/ Rhesus macaque FCERG/FCER1G monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T95400-Ab-1/ GM-Tg-felg-T95400-Ab-2Anti-Feline FCERG/FCER1G monoclonal antibodyFeline
GM-Tg-cang-T95400-Ab-1/ GM-Tg-cang-T95400-Ab-2Anti-Canine FCERG/FCER1G monoclonal antibodyCanine
GM-Tg-bovg-T95400-Ab-1/ GM-Tg-bovg-T95400-Ab-2Anti-Bovine FCERG/FCER1G monoclonal antibodyBovine
GM-Tg-equg-T95400-Ab-1/ GM-Tg-equg-T95400-Ab-2Anti-Equine FCERG/FCER1G monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T95400-Ab-1/ GM-Tg-hg-T95400-Ab-2; GM-Tg-rg-T95400-Ab-1/ GM-Tg-rg-T95400-Ab-2;
GM-Tg-mg-T95400-Ab-1/ GM-Tg-mg-T95400-Ab-2; GM-Tg-cynog-T95400-Ab-1/ GM-Tg-cynog-T95400-Ab-2;
GM-Tg-felg-T95400-Ab-1/ GM-Tg-felg-T95400-Ab-2; GM-Tg-cang-T95400-Ab-1/ GM-Tg-cang-T95400-Ab-2;
GM-Tg-bovg-T95400-Ab-1/ GM-Tg-bovg-T95400-Ab-2; GM-Tg-equg-T95400-Ab-1/ GM-Tg-equg-T95400-Ab-2
Products NameAnti-FCERG/FCER1G monoclonal antibody
Formatmab
Target NameFCERG
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCERG benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FCERG/ FCER1G/ FCRG VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004456human FCER1G Lentivirus particle
    ORF Viral VectorpGMLP004456human FCER1G Lentivirus plasmid
    ORF Viral VectorpGMLPm000085mouse Fcer1g Lentivirus plasmid
    ORF Viral VectorvGMLPm000085mouse Fcer1g Lentivirus particle


    Target information

    Target IDGM-T95400
    Target NameFCERG
    Gene ID2207,14127,25441,720291,403798,101089236,282226,100034137
    Gene Symbol and SynonymsCD23,Fce1g,FcepsilonRI,FCER1G,FcR-gamma,FCRG,FcRgamma,FcR[g],Ly-50
    Uniprot AccessionP30273,P20411,Q9BDR7
    Uniprot Entry NameFCERG_HUMAN,FCERG_RAT,FCERG_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000158869
    Target ClassificationN/A

    The target: FCERG, gene name: FCER1G, also named as FCRG. The high affinity IgE receptor is a key molecule involved in allergic reactions. It is a tetramer composed of 1 alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.